SEPTAX 1 G

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

CEFTAZIDIME AS PENTAHYDRATE

제공처:

BIOAVENIR LTD, ISRAEL

ATC 코드:

J01DD

약제 형태:

POWDER FOR SOLUTION FOR INJ/INF

구성:

CEFTAZIDIME AS PENTAHYDRATE 1000 MG

관리 경로:

I.M, I.V

처방전 유형:

Required

Manufactured by:

VIANEX S.A, GREECE

치료 그룹:

THIRD GENERATION CEPHALOSPORINS

치료 징후:

Septax is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• Nosocomial pneumonia• Broncho-pulmonary infections in cystic fibrosis• Bacterial meningitis• Chronic suppurative otitis media• Malignant otitis externa• Complicated urinary tract infections• Complicated skin and soft tissue infections• Complicated intra-abdominal infections• Bone and joint infections• Peritonitis associated with dialysis in patient on CAPD.Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.Ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.Ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (TURP).The selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic Gram negative bacteria.Ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.Consideration should be given to official guidelines on the appropriate use of antibacterial agents.

승인 날짜:

2021-12-31